Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

NCT04049331 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

240

Enrollment

OTHER

Sponsor class

Conditions

Hypogonadism, Male
Fatigue Syndrome, Chronic

Interventions

DRUG: Testosterone Undecanoate 750 MG/3 ML Intramuscular Solution [AVEED]
OTHER: placebo

Sponsor

Seattle Institute for Biomedical and Clinical Research